Josh has been involved in mentoring programs with Big Brothers since 1997, and has been responsible for implementing science and engineering leadership programs in Ontario and the Northwest Territories for Aboriginal non-Aboriginal communities. Josh is currently the Vice President of Corporate Development of Quantum Dental Technologies, and the CEO of Armour Therapeutics Inc in Toronto. Recently, Josh was Director of Business Development and Scientific Affairs at AXON consulting for biopharma and medical device companies engaged in clinical research and leading the global business development program in Toronto and New York City. Prior to AXON, Josh was an NSERC Post-Doctoral Fellow for three years conducting prostate cancer research at the Ontario Cancer Institute (OCI) in Toronto. During his 10 years in translational and biomedical research, Josh published over 20 scientific works, including publications in notable endocrinology and oncology journals. Josh is an active member in the Ontario biosciences sector, specifically with The Biotech Initiative (TBI), MaRS, and the Ontario Biosciences Industry Organization (OBIO) communities. Josh is on the Scientific Advisory Board of iProgen Biotech Inc. Josh has taught courses at the University of Guelph (Guelph), Michener Institute (Toronto), and the Togliatti Academy of Management (Togliatti, Russia). Josh had been acting as a research consultant for the Rotman School of Management/Ministry of Health and Long-Term Care on Ontario’s colorectal cancer care system. Josh is a graduate of the Richard Ivey School of Business at the University of Western Ontario, where he completed an MBA, specializing in the Health Sector as a Canadian Institute of Health Research “Science-to-Business” Fellow. He also holds a PhD as an NSERC Scholar in Biomedical Sciences and an Honours BSc in Molecular Biology and Genetics from the University of Guelph. Josh is an Action Canada Fellow from 2004.